| Biotechnology feed | All feeds
Results from a study by researchers at Yale School of Medicine and other... News-Medical.Net: Dec 9 2008 9:31AM Matching: antithrombin iii Find similar documents
20, 2008--The U.S.
Food and Drug Administration today issued an expedited approval of a supplemental application that allows for changes in the manufacturing of Sucraid (sacrosidase) Oral Solution.
The approval... Pharma Live: Nov 21 2008 11:42AM Matching: iii deficiency Find similar documents
10 /CNW Telbec/ - BELLUS Health Inc.
(NASDAQ: BLUS; TSX: BLU) reports results for the third quarter ended September 30, 2008.
For the three-month period ended September 30, 2008, the net loss amounted to $11,095,000 ($0... Stockwatch: Nov 10 2008 10:51PM Matching: iii deficiency Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.